KDM6A and lymphoma: Using a previously established experimental platform27, we analyzed whether UTX knockdown affects the cellular sensitivities towards 24 other types of anticancer drugs in Eμ-Myc;p19Arf−/− lymphoma cells (Fig. 5a, b).